Tradestie Institutional Equity Comparison Engine
OTLK vs CABA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
OTLK Overall Edge
OTLK Captures Institutional Edge (4โ0 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Outlook Therapeutics, Inc. Common Stock (OTLK) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, OTLK trades at 2.9x Forward P/E with 4781.8% operating margin (-99.4% YoY revenue) versus CABA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, OTLK sits in BREAKDOWN (55th %ile IV; Dealer Gamma Walls on Pro) against CABA sits in BREAKDOWN (30th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
OTLK
OTLK 2.9x vs CABA N/M Fwd P/E
Growth & Margin Winner
OTLK
Op Margin 4781.8% vs 0.0% ยท YoY -99.4% vs +0.0%
Momentum & Technical Winner
OTLK
1Y -73.0% vs -51.9% ยท 52W Pos 10% vs 0%
Options & Structure Winner
OTLK
BREAKDOWN (55th %ile IV) vs BREAKDOWN (30th %ile IV)
OTLK
NASDAQ
Outlook Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.40
-4.04% 1D
Market Cap
$107.1M
1M Return
-18.82%
1Y Return
-73.04%
Forward P/E
2.9x
Unified AI Score
48.6 / 100
HOLD
Tech 33.0
Fund 48.0
Flow 71.0
Mom 64.0
CABA
NASDAQ
Cabaletta Bio, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.12
-12.11% 1D
Market Cap
$286.9M
1M Return
-20.21%
1Y Return
-51.92%
Forward P/E
N/M
Unified AI Score
47.0 / 100
HOLD
Tech 33.0
Fund 52.0
Flow 66.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
OTLK -73.04%
CABA -51.92%
Spread: +21.12 pp (CABA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
OTLK TTM Op. Margin: 4781.8%
CABA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OTLK vs CABA. Trailing 12-month operating profitability (OTLK 4781.8% vs CABA 0.0%) and valuation multiples (OTLK 2.9x vs CABA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OTLK | CABA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $107.1M | $286.9M | Larger Scale | CABA |
| Trailing P/E Ratio Valuation | 2.9x | N/M | Lower Multiple | OTLK |
| Forward P/E Ratio Valuation | 2.9x | N/M | Lower Multiple | OTLK |
| Revenue Growth (YoY) Growth | -99.4% | +0.0% | Higher Growth | CABA |
| Operating Margin (TTM) Profitability | 4781.8% | 0.0% | Higher Margin | OTLK |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -3.6% | -89.5% | Higher ROE | OTLK |
| 52-Week Range Position Momentum | 10% ($0โ$3) | 0% ($1โ$4) | Stronger Trend | OTLK |
| Beta / 30D Volatility Risk Regime | 1.47ฮฒ ยท 79% Vol | 1.85ฮฒ ยท 101% Vol | Lower Realized Risk | OTLK |
| Unified Institutional Score Composite Signal | 48.6 / 100 (HOLD) | 47.0 / 100 (HOLD) | Higher Composite | OTLK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full OTLK vs CABA Buy Guide
OTLK
BREAKDOWN
103d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
55th %ile
IV Regime
Balanced (25thโ60th %ile)
CABA
BREAKDOWN
135d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
30th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither OTLK nor CABA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.